Finance

Lists
ACE:STO
Ascelia Pharma AB
SEK 0.63
+9.25%
(+0.053) 1D
Sep 18, 5:29:42 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ACE...
Open
SEK 0.59
High
SEK 0.65
Low
SEK 0.57
Mkt. cap
84.03M
Avg. vol.
888.67K
Volume
0.00
52-wk high
SEK 3.98
52-wk low
SEK 0.46
EPS
-SEK 0.48
Shares outstanding
133.54M
No. of employees
10
Open
SEK 0.59
High
SEK 0.65
Low
SEK 0.57
Mkt. cap
84.03M
Avg. vol.
888.67K
Volume
0.00
52-wk high
SEK 3.98
52-wk low
SEK 0.46
EPS
-SEK 0.48
Shares outstanding
133.54M
No. of employees
10
About Ascelia Pharma AB
CEOMagnus Corfitzen
Employees10
Founded1999
Headquarters-
SectorBiotechnology
Websiteascelia.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.89M
11.61M
14.16M
8.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.31M
4.12M
3.19M
3.36M
Operating expense
15.25M
15.53M
17.17M
12.16M
Total operating expenses
15.25M
15.53M
17.17M
12.16M
Operating income
-15.25M
-15.53M
-17.17M
-12.16M
Other non operating income
-
-218.00K
1.00K
-
EBT including unusual items
-15.72M
-15.93M
-17.03M
-12.21M
EBT excluding unusual items
-15.72M
-15.93M
-17.03M
-12.21M
Income tax expense
-50.00K
-67.00K
-648.00K
5.00K
Effective tax rate
0.32%
0.42%
3.81%
-0.04%
Other operating expenses
57.00K
-194.00K
-174.00K
2.00K
Net income
-15.67M
-15.86M
-16.38M
-12.21M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.13
-
-
Interest and investment income
427.00K
3.47M
398.00K
190.00K
Interest expense
-898.00K
-2.16M
-254.00K
-296.00K
Net interest expenses
-471.00K
1.31M
144.00K
-106.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.23M
-15.53M
-17.17M
-12.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps